Ownership history in Siren, L.L.C. · 6 quarters on record
This page tracks every 13F SEC filing in which Siren, L.L.C. reported a position in Silence Therapeutics PLC (SLN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 2,911,438 | — | 0% | 0.53% | $17.7M | $6.08 |
| 2025 Q3 | UNCHANGED | 2,911,438 | — | 0% | 0.59% | $15.1M | $5.19 |
| 2025 Q2 | ADDED | 2,911,438 | +121,605 | +4.4% | 0.87% | $16.9M | $5.80 |
| 2025 Q1 | REDUCED | 2,789,833 | -41,937 | -1.5% | 0.45% | $7.9M | $2.82 |
| 2024 Q4 | UNCHANGED | 2,831,770 | — | 0% | 0.86% | $19.5M | $6.88 |
| 2024 Q3 | INITIATED | 2,831,770 | — | — | 2.57% | $51.5M | $18.18 |
As of 2025 Q4 — sorted by position size